Publications by authors named "E De Cock"
Article Synopsis
- * Colchicine is currently the only anti-inflammatory medication showing promise for CAD, but more research is needed to fully understand its effectiveness and safety as a primary treatment option.
- * The COL BE PCI trial aims to evaluate the efficacy of colchicine versus placebo in 2,770 patients post-percutaneous coronary intervention (PCI), focusing on major cardiovascular events as the primary outcome of the study.
Introduction: Advanced age-related macular degeneration (AMD) is a major cause of vision loss. Therefore, there is interest in precursor lesions that may predict or prevent the onset of advanced AMD. One such lesion is a shallow separation of the retinal pigment epithelium (RPE) and Bruch's membrane (BM), which is described by various terms, including double-layer sign (DLS).
View Article and Find Full Text PDFChronic total occlusions (CTOs) are frequent in patients with previous coronary artery bypass graft (CABG) surgery. Percutaneous coronary intervention (PCI) is the usual revascularization strategy. Whether or not the presence of a graft on a CTO vessel and post-PCI graft patency impacts outcomes after CTO-PCI is unknown.
View Article and Find Full Text PDF